Anupam Rasayan India, a contract producer of specialty chemical compounds, introduced the signing of a definitive settlement to accumulate 100% of the fairness in Jayhawk Advantageous Chemical compounds Company, a U.S.-based specialty chemical compounds firm and a part of the CABB Group, for a purchase order consideration of $150 million.
The acquisition consideration consists of fee for the worth of Jayhawk inventory and current loans payable to exiting stockholders.
Contemplating Jayhawk’s money and money analogs of $16 million as of June 25, the acquisition consideration represents an enterprise worth of $134 million.
Jayhawker posted income and adjusted EBITDA of $78 million and $15 million, respectively, in CY24.
The acquisition will likely be financed by a mix of inside accruals, debt and quasi-equity from one of many world’s main funding administration companies.
Anand Desai, Managing Director, Anupam Rasayan India, mentioned: “This acquisition is a transformative step in Anupam’s international journey. Jayhawk has a heritage of innovation, deep buyer relationships and a robust know-how platform in high-value chemistry. “Collectively, we stay up for leveraging our complementary strengths to speed up development, develop our international presence, and ship higher worth to our clients throughout key sectors similar to aviation, semiconductors and electronics.”
“The addition of Jayhawk’s U.S. operations considerably strengthens our international footprint and brings us nearer to strategic clients in developed markets,” he added.
Tobias Scharrow, CEO of CABB Group, mentioned: “This transaction is a strategic step for our firm and we’ve taken this determination with the utmost confidence and belief in our new house owners. Now we have developed a scalable development platform within the pharmaceutical and life sciences specialisms and with this transaction we are going to additional develop and develop this, shifting away from industrial functions, electronics and semiconductors.”
